Recombinant adenoviruses and stem cells comprising same
AssigneeGenemedicine Co., Ltd.
InventorsChae Ok YUN, Yan LI
Life of this patent
Estimating the term…
Loading patent…
AssigneeGenemedicine Co., Ltd.
InventorsChae Ok YUN, Yan LI
Estimating the term…
The present invention relates to: recombinant adenoviruses, which have an excellent ability to be introduced into stem cells and can be easily introduced into stem cells even at a low concentration; stem cells comprising the same; a gene delivery composition; and a pharmaceutical composition. Stem cells into which adenoviruses are introduced, of the present invention, have excellent in vivo survivability and a treatment effect on tumor cells, and, when used as an anticancer drug, do not cause problems with respect to in vivo survival, hepatotoxicity and the like of stem cells so as to be particularly usable for systemic administration, and have an excellent anticancer effect even in small doses, thereby being widely usable as an anticancer drug using adenoviruses.
A mesenchymal stem cell (MSC) for anticancer comprising a recombinant adenovirus comprising a target gene and a sequence of SEQ ID NO:
A composition for delivering a gene, the composition comprising a mesenchymal stem cell in which a recombinant adenovirus comprising a target gene and a sequence of SEQ ID NO:
A pharmaceutical composition for treating cancer, the pharmaceutical composition comprising a pharmaceutically effective amount of a mesenchymal stem cell (MSC) in which a recombinant adenovirus comprising a target gene and a sequence of SEQ ID NO:
A recombinant adenovirus with enhanced stem cell transduction potency comprising a serotype 35 fiber knob.
Dependencies are inferred from the claim text.